US 10624959
Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria
granted A61KA61K31/198A61K31/205
Quick answer
US patent 10624959 (Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria) held by The Regents of the University of Colorado, a Body Corporate expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/198, A61K31/205, A61K31/385, A61K38/51